Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Fig S3 from HCK Promotes High-Grade Serous Ovarian Cancer Tumorigenesis through CD44 and NOTCH3 Signaling
  1. Home
  2. Publications
  3. Fig S3 from HCK Promotes High-Grade Serous Ovarian Cancer Tumorigenesis through CD44 and NOTCH3 Signaling

Fig S3 from HCK Promotes High-Grade Serous Ovarian Cancer Tumorigenesis through CD44 and NOTCH3 Signaling

Authors:
  • Christen A. Khella
    Christen A. Khella
  • LFLucyann Franciosa
    Lucyann Franciosa
  • LRLorna Rodirguez-Rodriguez
    Lorna Rodirguez-Rodriguez
  • RRResha Rajkarnikar
    Resha Rajkarnikar
  • KMKarthikeyan Mythreye
    Karthikeyan Mythreye
  • MGMichael L. Gatza
    Michael L. Gatza

Open Access
Publisher website
Google Scholar
  • 27 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1541-7786.30732727
Abstract
Cell line selection and engineering
Keywords
  • CELL SIGNALING
  • COMPUTATIONAL METHODS
  • GENE EXPRESSION PROFILING
  • GYNECOLOGICAL CANCERS
  • OVARIAN CANCER
  • ONCOGENES & TUMOR SUPPRESSORS
  • ONCOGENES
  • PROGRESSION, INVASION & METASTASIS
  • TUMOR PROGRESSION
  • PROTEOMICS
  • TRANSLATIONAL RESEARCH
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.